Research Associate II, QIPCM

Brandon Driscoll, MASc

Brandon is involved many facets of QIPCM and focusses mainly on helping investigators link their multi-center clinical trial imaging needs with QIPCM’s available services and resources. Brandon has led the development of the QIPCM Dosimetry program utilized for the OZM-067 NET-PRRT trial and adapted for use for standard of care Lutathera imaging at the Princess Margaret Cancer Centre. He is also the primary contact at QIPCM for multi-center scanner QA and validation for functional imaging including PET-CT/MR and DCE-CT.

Brandon obtained his Bachelor’s degree (B.A.Sc.) in Chemical Engineering with Software Option from the University of Waterloo in 2004. Throughout his co-op work terms Brandon gained experience in many facets of engineering from petro-chemicals and the automotive industry to computer programming. He went on to complete a Masters of Biomedical Engineering (M.A.Sc.) from the Institute of Biomaterials & Biomedical Engineering at the University of Toronto. His thesis focused on the development of an inhibitory peptide for the TGF-beta signal pathway in hematopoietic stem cells.

Privacy Preferences

When you visit our website, it may store information through your browser from specific services, usually in the form of cookies. Here you can change your Privacy preferences. It is worth noting that blocking some types of cookies may impact your experience on our website and the services we are able to offer.

Click to enable/disable Google Analytics tracking code.
Click to enable/disable Google Fonts.
Click to enable/disable Google Maps.
Click to enable/disable video embeds.
Our website uses cookies, mainly from 3rd party services. Define your Privacy Preferences and/or agree to our use of cookies.